MedTrace Logo

Evaluation of Cascade Screening for Elevated Lipoprotein(a)

NCT06157983 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1950

Last updated 2025-06-08

No results posted yet for this study

Summary

The aim of the current project is to evaluate the penetrance of elevated plasma Lp(a) levels in patients with atherosclerotic coronary artery disease to their first- and second-degree biological relatives based on data from a clinical health care development project.

Conditions

Interventions

OTHER

measurement of lipoprotein(a)

Plasma lipoprotein(a) will be measured in the biological relatives group as part of a clinical health care development project

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-01
Primary Completion
2025-06-16
Completion
2025-06-16

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06157983 on ClinicalTrials.gov